---
type: meeting
date: 2026-06-10
company: Chronicle Labs
attendees: Stephanie Perez, Derek Wu, Ayman Saleh
meeting_type: intro
transcript: "[[Chronicle Labs - 2026-06-10 Transcript]]"
created: 2026-06-10
tags:
  - meeting
---

[[Chronicle Labs]] | 2026-06-10 | Intro

## Attendees

- [[Ayman Saleh]] — Co-Founder & CEO, [[Chronicle Labs]]
- Stephanie Perez (Fin Capital)
- Derek Wu (Fin Capital)

## Transcript

[[Chronicle Labs - 2026-06-10 Transcript]]

## Company Overview

- Simulation environments for enterprise AI agents, built from production logs.
  - Captures events across enterprise systems, reconstructs them as replayable "traces."
  - Places agents into simulations to surface failures before they touch customers, revenue, or compliance.
  - Analogy: flight simulator / crash test facility for AI agents.
- Co-founders bring deep autonomous-systems pedigree:
  - **Ayman:** JPL/NASA, worked on Mars rover landing (hundreds of thousands of simulations pre-launch).
  - **Rawan (co-founder):** Boeing, led 737 Max fleet return to service, brokered Microsoft Flight Simulator pilot training integration.
- Core wedge: enterprises stuck in slow phased rollouts (5% of users, months of iteration) because no proper validation layer exists. Chronicle compresses that cycle via full production replay before launch.

## Product & Technical Approach

- Production-log capture across enterprise systems → reconstructed as replayable "traces."
- Agents placed into simulations against the full production scenario set before launch.
- Continuous-RL-loop vision: "agent factories" — a dashboard showing enterprises which agents are ready to spin up, back-tested against 180 days of production data.
- Data access:
  - One-click OAuth connectors for SaaS webhook events.
  - Self-hosted deployments (cloud-formation template in customer's AWS); customer owns all data.
  - SOC 2 Type 2 in progress; self-hosting has been sufficient for large enterprises and HIPAA customers.

## Traction

- **$45K MRR** as of 2026-06-10 — grown from $5K at YC entry (batch currently in progress).
- **Remedy Meds** (large US telehealth co., ~30% of US telehealth market by volume) — flagship case study.
  - Caught two critical agent failures pre-launch: retention offers sent to patients reporting side effects, and structurally impossible discount offers.
  - Fixed across all production scenarios and launched confidently within 48 hours.
  - Entry point: VP of Customer Support (Kofi) → trickled down to engineering.
- **Red Cat Holdings** (publicly traded) — largest paying customer, ~$200K ACV.
- **QC Healthcare** (pediatric) — pilot starting end of June 2026.
- Inbound pipeline (post-product-launch, ~3 weeks pre-meeting):
  - **Verizon** — LOI signed, ~1B calls/year, building agents fully in-house.
  - **Row Banking** — pilot expected end of month.
  - **American Express** and **Adyen** — in advanced conversations.

## Pricing & Competition

- Target ACV ~$100K; founder believes pricing is currently low. Usage-based expansion expected as agent adoption grows.
- **Competitive positioning:** no direct competitors building enterprise simulators.
  - Observability tools (Braintrust, Raindrop) — Chronicle **integrates with Braintrust** rather than competing.
  - ~75% of use cases are enterprises building their own agents (not adopting agent builders like Sierra or Giga).
  - **Handshake AI** (RL environments, lab-aligned) approached with acquisition offer — declined.

## Financing & Growth

- Raising **$4M on $40M cap**; **$1M already closed**. Fundraise launched Monday 2026-06-08.
- Seeking investors with enterprise + banking distribution. Ayman's Deutsche Bank background is the GTM leverage point.
- Currently in YC batch.

## Next Steps

- Ayman to send pitch deck to Derek and Stephanie.
- Stephanie to share feedback and portfolio conflict-check outcome by 2026-06-11.
- Fin process: portfolio conflict check → diligence → IC → partner presentation.
